Ronda Greaves

Honorary Principal Fellow - Associate Professor

University of Melbourne

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Microbiology Microbiology professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ronda Greaves is an Honorary Principal Fellow and Associate Professor at the University of Melbourne, Australia. Her research focuses on laboratory medicine, newborn screening, and the application of emerging technologies in health diagnostics. Recent publications include contributions to guidelines on sweat chloride testing for cystic fibrosis and studies addressing bilirubin measurements in neonates. Professor Greaves is also involved in the evaluation of clinical and statistical significance in laboratory practices.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (5)

Rosita Zakaria

Lecturer

RMIT University

AUSTRALIA

View details

Corey Markus

AUSTRALIA

View details

James Pitt

Head of Newborn & Metabolic Screening

Murdoch Childrens Research Institute

AUSTRALIA

View details

Thilini Thrimawithana

Senior Lecturer

RMIT University Bundoora Campus

AUSTRALIA

View details

David J. Amor

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ronda Greaves

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Australasian guideline for the performance of sweat chloride testing 3rd edition: to support cystic fibrosis screening, diagnosis and monitoring

High-throughput assessment of FMR1 and SNRPN methylation-based newborn screening using IsoPure and QIAcube HT systems

Clinical vs. statistical significance: considerations for clinical laboratories

Contribution of laboratory medicine and emerging technologies to cardiovascular risk reduction via exposome analysis: an opinion of the IFCC Division on Emerging Technologies

Is sweat conductivity still a relevant screening test for cystic fibrosis? Participation over 10 years

Managing Newborn Screening Repeat Collections for Sick and Preterm Neonates

Bilirubin measurements in neonates: uniform neonatal treatment can only be achieved by improved standardization

Linearity assessment: deviation from linearity and residual of linear regression approaches

Six years of progress – highlights from the IFCC Emerging Technologies Division

The LEAP checklist for laboratory evaluation and analytical performance characteristics reporting of clinical measurement procedures

Quality assurance programs for vitamin A and E in serum: are we doing enough to assess laboratory performance?

A new door to a different world: opportunities from the metaverse and the raise of meta-medical laboratories

The development of reference measurement procedures to establish metrological traceability

Toolkit for emerging technologies in laboratory medicine

Method validation for a greener approach to the quantification of 25-hydroxy vitamin D3 in patient serum using supported liquid extraction and liquid chromatography-tandem mass spectrometry

Method evaluation in the clinical laboratory

Difference- and regression-based approaches for detection of bias

Endogenous isobaric interference on serum 17 hydroxyprogesterone by liquid chromatography-tandem mass spectrometry methods

Emerging technology: a definition for laboratory medicine

Fifty years of newborn screening for congenital hypothyroidism: current status in Australasia and the case for harmonisation

Collaborators (5)

Rosita Zakaria

Corey Markus

James Pitt

Thilini Thrimawithana

David J. Amor

Make your next move.